Application

17620239 · EGFR INHIBITOR FOR THE TREATMENT OF CANCER

Filed 2021-12-17 · Granted · Patent 12344613 (2025-07-01) The official file ↗The patent and its PDF ↗ · Art unit 1624 · Examiner Susanna Moore Typical · CPC C07D 487/04 · Hoffmann-La Roche Inc. · GENENTECH, INC.

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

33.4 mo

to disposition 42.4 mo

Statutes raised

112 DP

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.